STAT1 and lung carcinoma: Additionally, ROP16 can polyubiquitinate STING, inhibiting the cGAS-STING signaling pathway, reducing inflammatory cytokine secretion, and inhibiting STAT1 and NF-κB pathways, ultimately preventing brain metastasis of breast and lung cancer.